Quick Summary
Romstim 125mcg Injection
Last updated on 07 Aug 2026 | 05:49 AM (IST)
₹1350
MRP: ₹1687.5
(You Save ₹337.5)
1 VIAL(s)
Romstim 125mcg Injection
Salt Composition
ROMIPLOSTIMMarketer
HETERO HEALTHCARE LTD
Prepaid Only. Non-Returnable.
20% OFF
₹1350
MRP: ₹1,687.50
Inclusive of all taxes
20% Off
Salt Composition
ROMIPLOSTIMMarketer
HETERO HEALTHCARE LTD
Prepaid Only. Non-Returnable.
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Romiset 125mcg Injection 6ml
ALKEM LABORATOR...
₹ 2079.00/injection
54% costlier
Augplat 125mcg Injection
ZYDUS CADILA
₹ 2098.00/injection
56% costlier
Introduction
Romstim 125mcg Injection belongs to the platelet-stimulating agent category and contains Romiplostim. It is used to treat immune primary thrombocytopenia (ITP), a condition in which the body’s immune system mistakenly destroys its own platelets, leading to low platelet counts. This medicine is mainly prescribed for adults and children aged 18 years and above when other treatments have not worked. It is generally recommended when immunoglobulins, corticosteroids, or splenectomy have failed to improve platelet levels. This treatment purpose aligns with What is Romstim 125mcg Injection used for?, as the lower-strength formulation is used for the same therapeutic indication with dose adjustments based on platelet response.
This drug is contraindicated in individuals with known hypersensitivity to Romiplostim or medicines produced using E. coli-based DNA technology. Before receiving this injection, inform your physician if you have liver disorders, cancer, a recent surgery, smoking habits, or if you are taking birth control pills. These factors can influence the medication’s effectiveness and safety, helping your physician determine if adjustments are necessary.
During treatment, your physician will conduct regular blood tests to check for abnormalities that may indicate bone marrow changes. Romiplostim has been associated with significant bone marrow alterations, so ongoing monitoring is essential. Based on test results, your doctor may decide whether to continue or discontinue therapy. The medication is not recommended during pregnancy unless clearly advised by your doctor. If pregnant, planning pregnancy, or suspecting pregnancy, you must inform your physician. Since it is unknown whether the drug passes into breast milk, breastfeeding should be avoided.
For cost-related queries, the Romstim 125mcg Injection price may vary depending on location and pharmacy. Patients seeking convenience may choose to Buy Romstim 125mcg Injection online from verified medical platforms. Awareness of potential Romstim 125mcg Injection side effects is important, which may include headache, dizziness, bone pain, or injection-site reactions. If Romstim is not suitable, your doctor may recommend Romstim 125mcg Injection substitutes that provide similar therapeutic effects.
Uses
Treatment of immune thrombocytopenia (ITP)
How Romstim 125mcg Injection Works
Romstim 125mcg Injection works by stimulating the production of platelets in the bone marrow. It binds to and activates the thrombopoietin receptor, which promotes the development and maturation of platelets. This helps to increase the platelet count in individuals with ITP.
Interaction of Romstim 125mcg Injection with other drugs
Thiazide Diuretics (Severe)
Drugs like hydrochlorothiazide may raise blood calcium when combined with Romstim, increasing toxicity risk. Dose adjustment and monitoring are essential.Digoxin (Moderate)
High calcium levels caused by Romstim may increase the risk of digoxin toxicity. Heart rhythm and serum digoxin levels should be monitored.Magnesium-Containing Antacids (Moderate)
Romstim may enhance magnesium absorption, potentially causing electrolyte imbalance. Monitoring is advised in long-term use.Corticosteroids (Moderate)
Steroids such as prednisone may reduce the effectiveness of Romstim by interfering with calcium metabolism. Dose adjustments may be needed.Phosphate Binders (Mild)
Concurrent use may slightly alter phosphate and calcium balance. Periodic blood tests are recommended to ensure safe levels.
Storage Conditions
Store Romstim 125mcg Injection in a refrigerator (2°C - 8°C).
Do not freeze.
How to use Romstim 125mcg Injection
Romstim 125mcg Injection will be administered to you by a healthcare professional in a hospital setting. It is usually administered as a subcutaneous injection (under the skin). Your doctor will decide the dose, route of administration, and frequency based on your disease condition and other factors.
Safety Advices
Pregnancy
Romstim 125mcg Injection is not recommended for pregnant patients unless specifically indicated by your doctor. Inform your physician if you are pregnant, suspecting, or planning for a pregnancy before initiating the treatment.
Breast Feeding
It is not known whether Romstim 125mcg Injection is present in human milk. Therefore, this drug is not recommended for use while breastfeeding.
Lungs
It is unknown whether Romstim 125mcg Injection is safe for patients with lung problems. Inform your physician if you have lung disease before starting the treatment.
Liver
It is unknown whether Romstim 125mcg Injection is safe for patients with liver problems. Inform your physician if you have liver disease before starting the treatment.
Alcohol
It is unknown whether consuming alcohol interacts with Romstim 125mcg Injection. Please consult your doctor for more advice.
Driving
Some side effects of Romstim 125mcg Injection may impair your ability to drive or operate machinery safely. It is advisable to discuss this with your doctor before engaging in such activities.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious
Loss of response
Progression of Myelodysplastic Syndromes
Thromboembolic complications
Leukemia
Higher risk of blood clots
Common
Headache, dizziness
Allergic reaction
Upper respiratory tract infection
Joint pain, muscle pain
Indigestion
Sleeping trouble
Tingling or numbness of the feet or hands
Abdominal pain, diarrhoea, and indigestion
Fever, cough
Expert tips
Always take Romstim 125mcg Injection under medical supervision in a hospital or clinic.
Regularly monitor your platelet counts as advised to track treatment progress and safety.
Inform your doctor if you're on blood thinners, as they may increase bleeding risk.
Watch for signs of blood clots like limb pain or shortness of breath and report them immediately.
Tell your doctor about any unusual symptoms like dizziness or fatigue during treatment.
FAQs
Q1.
What precautions should be taken before using Romstim 125mcg Injection?
Before taking Romstim 125mcg Injection, it is important to inform your physician about any liver problems, history of cancer, recent surgeries, smoking habits, and the use of birth control pills. These factors may affect the safety and effectiveness of the medication, and your physician needs to be aware of them.
Q2.
What are the common side effects of Romstim 125mcg Injection?
The most common side effects of Romstim 125mcg Injection include headache and respiratory tract infections. However, side effects can vary from person to person. If you experience any concerning side effects or have any concerns, it is advisable to consult your physician.
Q3.
What is the correct method of administering Romstim 125mcg Injection?
Romstim 125mcg Injection is administered through subcutaneous injections (under the skin). Your physician will provide the specific dosing and administration instructions.
Q4.
What is the working mechanism of Romstim 125mcg Injection?
Romstim 125mcg Injection works by stimulating the production of platelets in the bone marrow. It binds to and activates the thrombopoietin receptor, promoting platelet development and maturation. This helps to increase the platelet count in individuals with ITP.
Q5.
Can Romstim 125mcg Injection be used in children?
Romstim 125mcg Injection is approved for use in adults and children aged 18 years and over with immune primary thrombocytopenia (ITP) when other treatments are ineffective. The paediatrician will determine the dosing and administration.
Fact Box
Molecule name | Romiplostim |
Therapeutic class | Platelet-stimulating agents |
Pharmacological class | Thrombopoietin receptor agonists |
Indications | Treatment of immune thrombocytopenia (ITP) |
References
Amgen Limited, Electronic medicines compendium (EMC), [ Revised on Oct 2021] [ Accessed on 14th July 2023],https://www.medicines.org.uk/emc/files/pil.567.pdf
Amgen Inc, US Food and Drug Administration, [ Revised on Dec 2018] [Accessed on 14th July 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/125268s163lbl.pdf
Douglas B.cines et al.; Safety and efficacy of romiplostim in splenectomized patients with primary immune thrombocytopenia; Haematologica; Published on August 2017; Accessed on 14th July 2023; https://www.haematologica.org/article/view/8154
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
P. Thirumal Reddy
B. Pharm
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 07 Aug 2026 | 05:49 AM (IST)
Want to know more?
Read Our Editorial Policy
.jpg&w=640&q=70&dpl=dpl_HTr3XfzYmcTc2VRAYZs84xTK5ncb)
